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Effects of Chronic Arsenic Exposure
on Hematopoietic Function in
Adult Mammalian Liver
by James S. Woods* and Bruce A. Fowler*
In these studies the effects of ingested arsenic (As+15) on hepatic heme biosynthetic capability and
hemoprotein function in adult male rats were investigated. Animalsexposed for 6 weeks to 0, 20, 40, or 85
ppm sodium arsenate in the drinking water suffered depression of hepatic 8-aminolevulinic acid (ALA)
synthetase and heme synthetase (ferrochelatase) activities, with maximal decreases to 67 and 55% of
control levels, respectively, at 85 ppm. Concomitantly, urinary uroporphyrin levels were elevated by as
much as 12 times, and coproporphyrin by as much as 9 times, control values. The rate ofincorporation of
3H-ALA into mitochondrial and microsomal hemes was depressed by 40-50%o at 20 ppm but was in-
creased with regard to controls by as much as 150%o at the higher treatment levels. A similar biphasic
pattern was observed in regard to "4C-leucine incorporation into cellular membranal proteins. In con-
trast, the levels of ALA dehydratase, uroporphyrinogen I synthetase, aminopyrine demethylase, and
cytochrome P-450 were not significantly changed in As+5-treated rats. These results support the
hypothesis that chronic, low level, arsenic exposure results in selective inhibition ofmitochondrial-bound
heme biosynthetic pathway enzymes (ALA synthetase and heme synthetase) resulting in a substantial
increase in urinary porphyrins, uniquely characterized by a greater increase in uroporphyrin than
coproporphyrin levels. These changes occur independent of, or prior to, alterations in hepatic
hemoprotein-dependent functions and may thus serve in the clinical analysis of pretoxic exposure to
arsenic compounds in human populations.
Introduction
Previous papers in this session have attested to
the variety of potentially toxic effects of arsenic
compounds on specific organ functions following
chronic low-level exposure in mammals. In this
paper the results of experiments which were de-
signed to assess the effects of inorganic arsenic
compounds on hematopoietic function in adult
mammalian liver are described.
Figure 1 presents a schematic representation of
the heme biosynthetic pathway, which is responsi-
ble for hematopoiesis in adult mammalian tissues.
This process in normal tissues is regulated primarily
by the first and rate-limiting enzyme in this path-
way, 8-aminolevulinic acid (ALA) synthetase (1).
Other important enzymes in the heme biosynthetic
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pathway include ALA dehydratase, uropor-
phyrinogen I synthetase, and heme synthetase (fer-
rochelatase), all of which are known to limit heme
biosynthetic capability under various physiological
or toxicological conditions (2).
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FIGURE 1. Heme biosynthetic pathway: URO=uroporphyrinogen,
COPRO=coproporphyrinogen, PROTO=protoporphyrin.
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209The hematopoietic system in organs such as
liver, kidney, and other nonerythropoietic tissues
plays the extremely important role in these organs
of providing heme for the biosynthesis of hemo-
proteins such as the mitochondrial and microsomal
cytochromes, which are essential to cellulargrowth
and function. This system is known to be highly
susceptible to alteration by many drugs and other
environmental chemicals, particularly trace metals
(2, 3), and it is altogether appropriate, therefore,
that it be considered as apotential target systemfor
arsenic compounds in animals which are chroni-
cally exposed to these agents.
In the present studies the potential hematotoxic-
ity ofsodium arsenate on hematopoietic function in
adult rat liver was investigated. A variety of
parameters designed to measure the effects ofarse-
nic on both heme biosynthetic capability and
hemoprotein function were examined, and the util-
ity of the findings in the prediction of pretoxic ex-
posure to environmental arsenic compounds in
human populations was assessed.
Materials and Methods
Treatment of Animals
Male Sprague-Dawley rats (CD strain), obtained
from the Charles River Laboratories, Boston, Mas-
sachusetts, were divided into four groups of 12 ani-
mals each and were placed in individual wire bot-
tom cages in barrier isolation rooms. Animals were
given access to laboratory chow and deionized
drinking water containing 0, 20, 40, or 85 ppm arse-
nic as sodium arsenate forup to 6weeks. Inurinary
porphyrin studies, animals were placed in indi-
vidual metabolism cages for the collection ofurine
over a 16-hr period immediately preceding the
analysis ofurinary heme precursors. Inpulse-label-
ing studies, animals were given 20 gCi 14C-leucine
or 60 gCi 8-aminolevulinic-3,5-3H(N) acid by in-
traperitoneal injection 10 min prior to sacrifice.
Isotopes were obtained from New England Nu-
clear, Boston, Massachusetts.
Preparation of Tissues
Animals were killedbydecapitation. Livers were
rapidly excised, washed, weighed, andhomogenized
in 9 volumes of 0.25M sucrose containing 0.05M
Tris-HCl buffer, pH 7.5 in a Potter-Elvehjem
homogenizer fitted with a Teflon pestle. Mitochon-
driaand microsomalfractions were thenprepared as
previously described (4).
Assay ofEnzyme Activities
ALA synthetase activity in hepatic mitochondria
was measured as previously described (4). Reaction
mixtures contained approximately 4 mg mitochon-
drial protein/ml.
ALA dehydratase activity was measured in 9000g
supernatant fractions of liver and kidney homoge-
nates by a modification of the method of Gibson et
al. (5), as described by Baron and Tephly (6).
Uroporphyrinogen I synthetase activity in liver
and kidney preparations was measured in the 9000 g
supernatant fractions after heating at 65°C for 15
min, as previously described (2).
Mitochondrial ferrochelatase activity was mea-
suredby amodification ofthemethodofPorra(7)by
using mesoporphyrin-IX dihydrochloride as sub-
strate. Reaction mixtures containing 0.25 gLmole
mesoporphyrin-IX, 4.0 ,imole reduced glutathione,
0.5 ,Lmole FeSO4, 1.65 ml of0.05MTris-HCl buffer,
pH 7.6, and 10 mg ofmitochondrial protein in atotal
volume of 3.25 ml were flushed extensively with
oxygen-free N2, capped with anerobic test-tube
stoppers, andincubated with shakingfor 1 hr at370C
in a N2 atmosphere. Reactions were terminated by
the addition of 0.3 ml of 0.4M iodoacetamide, 1 ml
pyridine, 0.5 ml IN NaOH and 2.5 ml water. Mix-
tures were then centrifiged for 10 min at 9500 rpm.
The clear supernatant solution was divided between
two matched cuvettes, and the reduced minus ox-
idized spectrum, obtained after adding Na2S204 or
K3Fe(CN)6 to separate cuvettes, was recorded fiom
600 to 500 nm by using a Beckman Acta III record-
ing spectrophotometer. The concentrations of the
pyridine mesohemochromes were calculated as de-
scribed by Porra (7), a value of21.7 being used for
the molar absorbance.
Cytochrome P450 levels in rat liver microsomes
were determined by difference spectrophotometry
using the method of Omura and Sato (8). Mi-
crosomal aminopyrine demethylase and mito-
chondrial cytochrome oxidase activities were meas-
ured as previously described (2).
Protein determinations were made by the method
of Lowry et al. (9) using bovine serum albumin
(Fraction V) as a standard.
Quantitation and Assessment of3H-ALA In-
corporation Into Mitochondrial Hemes
Mitochondrial hemes were extracted according to
the method ofRieske (10). The mitochondrial pellet
was homogenized successively with acetone,
chloroform:methanol (2:1, vN), and acetone. The
supematantsolutionremainigaftercentrifugationat
9000 rpm for 15 min was discarded, and the pellet
was extracted 3 times for 15 min each with 10 vol-
umes of acetone:HCI (0.9 ml of concentrated HCI
per 100 ml ofacetone). The combined acetone:HC1
extracts were then evaporated to dryness in vacuuo.
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pyridine, and an aliquot was removed for counting in
a Packard Tri-Carb liquid scintillation spectrometer
with appropriate corrections for quenching. Meas-
urements were made in glass counting vials using 10
ml Biofluor (New England Nuclear) as counting sol-
ution. The heme content was determined by the
pyridine hemochromogen method as described by
Rieske (10).
Quantitation and Assessment of 3H-ALA In-
corporation Into Microsomal Hemes
Microsomal hemes were quantitated by the
pyridine hemochromogen method as described by
Falk (11). Microsomal pellets were suspended in
0.05M Tris-HCI buffer, pH 7.5, so as to contain ap-
proximately 2 to 3 mg ofprotein/ml. An aliquot was
removed for counting in a liquid scintillation spec-
trometer by using 20 ml of PPO-POPOP counting
solution. The microsomal heme content was calcu-
lated from the difference in absorption between 541
and 557 nm, a value of20.7 being used for the molar
absorbance.
Assessment of "IC-Leucine Incorporation
into Mitochondrial and Microsomal Frac-
tions
In this step, 1-mi fractions of washed mitochon-
drial or microsomal pellets were dissolved in equal
portions of0.4N NaOH, and aliquots were counted
in a liquid scintillation spectrometer, as described
above.
Quantitation of Urinary Heme Precursors
Urinary ALA and PBG were determined by the
colorimetric procedure described by Mauzerall and
Granick (12) and modified by Davis and Andelman
(13). Urinary levels of uroporphyrin and copropor-
phyrin were determined fluorometrically, as de-
scribed by Talman and Schwartz (14).
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FIGURE 2. Effects ofexposure to sodium arsenate on activities of
heme biosynthetic pathway enzymes in rat liver. Values in
this and subsequent figures represent means + standard er-
rors ofat least five experiments and are expressed as percent
of control.
mately 55% of control (0 ppm) levels at 85 ppm.
Concomitantly, ALA synthetase was also depressed
at higher arsenic dose levels, attaining a maximal
depression to approximately 67% ofcontrol levels at
85 ppm.
Accompanying this decrease in heme biosynthetic
pathway enzyme activities was a substantial eleva-
tion of urinary uroporphyrin and coproporphyrin
levels in animals exposed to high doses of arsenic.
As indicated in Figure 3, uroporphyrin levels were
increased to almost 12 times control values, whereas
coproporphyrin was increased to approximately 9
times the controls. This observation is of particular
interest, since in most known cases of chemical
prophyria coproporphyrin levels almost always ex-
ceed those of uroporphyrin (15). This unusual pat-
tern of urinary porphyrin excretion, therefore, may
be uniquiely characteristic of arsenic exposure, an
observation which could be ofutility in the detection
of subclinical arsenic toxicity in humans.
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Results and Discussion
The effects of continuous exposure to sodium
arsenate on the activities ofheme biosynthetic path-
way enzymes in rat liver are presented in Figure 2.
Exposure to arsenic at the lowest dose level (20 ppm)
had very little effect on any of these enzymes. The
one significant change which occurred at this dose
level was an approximate 20%o inhibition of heme
synthetase, the final enzyme in the heme biosynthe-
tic pathway. With increasing dose levels of arsenic
exposure, heme synthetase was further depressed,
achieving a maximal decrease in activity to approxi-
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FIGURE 3. Levels ofporphyrins and heme precursors in urine of
rats during chronic exposure to sodium arsenate.
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211The observed changes in heme biosynthetic path-
way enzymes and urinary prophyrin levels occurred
independently of, or prior to, any overall changes in
hemoprotein function in the liver (Fig. 4). Levels of
aminopyrine demethylase and cytochrome P-450,
which serve as indicators of microsomal hemopro-
tein function, were not substantially altered in
arsenic-treated animals. Levels of cytochrome ox-
idase, a measure ofmitochondrial hemoprotein func-
tion, were actually increased in livers of arsenic-
exposed rats, although no change from the control
levels in the activity of this enzyme were seen in
arsenic-treated mouse liver (unpublished observa-
tions). Thus, elevation of urinary porphyrin levels
occurs prior to the onset of overt changes in hepatic
hemoprotein function and may represent one of the
initial manifestations of arsenic exposure.
2
1 200
:t=
0
>1
.t
O 100
E
N
,
cy
oxi
aminopyrine
demethylase
fT
(tochrome
Jdase
0 2040 85 0 204085
Dose (ppm)
cytochrome
P-450
KrnVT
0 20 40 85
FIGURE 4. Effects of exposure to sodium arsenate on cyto-
chrome oxidase and mixed function oxidase activities in rat
liver.
Perhaps a more sensitive indicator of heme
biosynthetic capability in mammalian tissues is
measured by the rate of incorporation of radio-
labeled heme precursors into mitochondrial and mi-
crosomal hemes of exposed animals. It was, there-
fore, of interest to determine if differences in heme
biosynthetic capability, as measured by the pulse
labeling technique, in control versus arsenic-exposed
rats could be observed. In these studies, animals
were given pulse doses of tritiated ALA (60 ,uCi),
and the rate of incorporation of the labeled heme
precursor into hepatic mitochondrial and microsomal
hemes in vii'o was measured per unit of time. The
results of these experiments are shown in Figure 5.
These experiments indicated that the rate ofincorpo-
ration of H-3-ALA into both mitochondrial and mi-
crosomal hemes was substantially reduced by as
much as 40-50% at the 20 ppm exposure level. At
higher levels, however, a paradoxical reversal ofthis
reduced incorporation phenomenon was observed,
with the rate ofincorporation of3H-ALA into hepat-
ic hemes reaching almost 200% with regard to con-
trols at 85 ppm.
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FIGURE 5. Incorporation of 3H-ALA into hepatic mitochondrial
and microsomal hemes during chronic exposure to sodium
arsenate in rats.
This observation suggested an actual increase in
the utilization of hepatic heme at higher arsenic ex-
posure levels. Since the specific activities of hemo-
proteins were not increased in livers ofarsenic-treated
rats, however, and since the levels of heme
biosynthetic pathway enzymes were actually de-
creased in these animals, it did not appear that these
incorporation patterns could be attributed to specific
changes in heme biosynthetic capability or an in-
creased demand for heme per se. Therefore, further
pulse-labeling studies were performed in order to de-
termine if the increase in labeling of hepatic hemes
following arsenic exposure was a reflection of a more
general alteration in hepatocellular proliferative ac-
tivity. In these studies, animals were pulse labeled
with 14C-leucine (20 ,Ci), and the rate of incorpora-
tion of this precursor into the membranal proteins of
cellular organelles was examined.
Again, a biphasic pattern of incorporation, similar
to that seen in the case of 3H-ALA was observed
(Fig'. 6). A marked depression ofthe incorporation of
leucine into cellular proteins which occurred after
exposure to low levels of arsenic was translated into
an actual stimulation of this activity at higher levels
of exposure.
These studies suggest that the increased labeling
ofhepatic hemes observed in arsenic-exposed rats is
not a specific effect but rather is probably a reflec-
tion of a more general proliferation of cellular mem-
branal components which occurs during arsenic ex-
posure. The rapid labeling of both hemes and mem-
branal proteins in liver cells of arsenic exposed rats
provides a biochemical correlation with the ultra-
structural studies previously described (16), dem-
onstrating the rapid proliferation of cellular mem-
branal components in arsenic-treated animals. This
type of observation, in which one finds a hyper-
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FIGURE 6. Incorporation of 14C-leucine into hepatic mitochon-
drial and microsomal proteins during chronic exposure to
sodium arsenate in rats.
trophic proliferation of membranes of cellular or-
ganelles, which is not associated with a correspond-
ing increase in the activities of many of the enzymes
which are normally found in these membrane sys-
tems, is one which is characteristic ofthe response of
the liver to a variety of chemicals during the induc-
tion of chronic liver disease (17).
While no specific manifestations of chronic liver
disease nor loss or organ function have been dem-
onstrated in these investigations, these studies do
suggest that such consequences could result after
chronic exposure to arsenical agents. It is, therefore,
of the greatest interest that the identification of
biochemical and other metabolic changes which
occur during the early phases ofarsenic exposure be
made. Among these alterations identified in the pres-
ent studies are specific changes in hepatic heme
biosynthetic pathway enzymes, resulting in an un-
usual pattern ofporphyrin excretion in urine ofarse-
nic exposed animals. This pattern differs from those
produced by most other prophyrogenic environmen-
tal agents (3, 15) and may, therefore, be of value in
the design of clinically useful tests for monitoring
pretoxic exposure to arsenic compounds in human
populations.
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